The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries

PURPOSE: The aim of this study is to investigate the role of health-related quality-of-life (QoL) data in relative effectiveness assessments (REAs) of new anti-cancer drugs across European jurisdictions, during health technology assessment procedures. METHODS: Comparative analysis of guidelines and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleijnen, Sarah, Leonardo Alves, Teresa, Meijboom, Kim, Lipska, Iga, De Boer, Anthonius, Leufkens, Hubertus G., Goettsch, Wim G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548837/
https://www.ncbi.nlm.nih.gov/pubmed/28401419
http://dx.doi.org/10.1007/s11136-017-1574-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548837/
https://www.ncbi.nlm.nih.gov/pubmed/28401419
http://dx.doi.org/10.1007/s11136-017-1574-9

Ejemplares similares